人工膵臓デバイスシステムの世界市場2021-2026:一時停止しきい値デバイスシステム、ハイブリッド閉ループAPDS、その他システム

LP Informationが発行した調査報告書(LPI21JL16440)
◆英語タイトル:Global Artificial Pancreas Devices Systems Market Growth 2021-2026
◆商品コード:LPI21JL16440
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:131
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LP Information社の「人工膵臓デバイスシステムの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、一時停止しきい値デバイスシステム、ハイブリッド閉ループAPDS、その他システムなど、用途別には、病院、クリニックなどにセグメント区分してまとめました。人工膵臓デバイスシステムのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・人工膵臓デバイスシステムの世界市場概要(サマリー)
・人工膵臓デバイスシステムの企業別販売量・売上
・人工膵臓デバイスシステムの企業別市場シェア
・人工膵臓デバイスシステムの世界市場規模 2016年-2021年:種類別(一時停止しきい値デバイスシステム、ハイブリッド閉ループAPDS、その他システム)
・人工膵臓デバイスシステムの世界市場規模 2016年-2021年:用途別(病院、クリニック)
・人工膵臓デバイスシステムの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・人工膵臓デバイスシステムのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・人工膵臓デバイスシステムのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・人工膵臓デバイスシステムの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・人工膵臓デバイスシステム市場の成長要因・課題・動向
・人工膵臓デバイスシステムの世界市場予測 2021年-2026年
・人工膵臓デバイスシステムの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・人工膵臓デバイスシステムのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・人工膵臓デバイスシステムのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・人工膵臓デバイスシステムの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・人工膵臓デバイスシステムの世界市場予測:種類別(一時停止しきい値デバイスシステム、ハイブリッド閉ループAPDS、その他システム)
・人工膵臓デバイスシステムの世界市場予測:用途別(病院、クリニック)
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Artificial Pancreas Devices Systems will have significant change from previous year. By the most conservative estimates of global Artificial Pancreas Devices Systems market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 79 million in 2020. Over the next five years the Artificial Pancreas Devices Systems market will register a 12.6% CAGR in terms of revenue, the global market size will reach US$ 127.2 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Pancreas Devices Systems market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals
Clinics

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Pancreas Devices Systems Consumption 2016-2026
2.1.2 Artificial Pancreas Devices Systems Consumption CAGR by Region
2.2 Artificial Pancreas Devices Systems Segment by Type
2.2.1 Threshold Suspended Device Systems
2.2.2 Hybrid Closed-loop APDS
2.2.3 Other Systems
2.3 Artificial Pancreas Devices Systems Sales by Type
2.3.1 Global Artificial Pancreas Devices Systems Sales Market Share by Type (2016-2021)
2.3.2 Global Artificial Pancreas Devices Systems Revenue and Market Share by Type (2016-2021)
2.3.3 Global Artificial Pancreas Devices Systems Sale Price by Type (2016-2021)
2.4 Artificial Pancreas Devices Systems Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Artificial Pancreas Devices Systems Sales by Application
2.5.1 Global Artificial Pancreas Devices Systems Sale Market Share by Application (2016-2021)
2.5.2 Global Artificial Pancreas Devices Systems Revenue and Market Share by Application (2016-2021)
2.5.3 Global Artificial Pancreas Devices Systems Sale Price by Application (2016-2021)

3 Global Artificial Pancreas Devices Systems by Company
3.1 Global Artificial Pancreas Devices Systems Sales Market Share by Company
3.1.1 Global Artificial Pancreas Devices Systems Sales by Company (2019-2021)
3.1.2 Global Artificial Pancreas Devices Systems Sales Market Share by Company (2019-2021)
3.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Company
3.2.1 Global Artificial Pancreas Devices Systems Revenue by Company (2019-2021)
3.2.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Company (2019-2021)
3.3 Global Artificial Pancreas Devices Systems Sale Price by Company
3.4 Global Manufacturers Artificial Pancreas Devices Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artificial Pancreas Devices Systems Product Location Distribution
3.4.2 Players Artificial Pancreas Devices Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Artificial Pancreas Devices Systems by Region
4.1 Global Artificial Pancreas Devices Systems by Region
4.1.1 Global Artificial Pancreas Devices Systems Sales by Region
4.1.2 Global Artificial Pancreas Devices Systems Revenue by Region
4.2 Americas Artificial Pancreas Devices Systems Sales Growth
4.3 APAC Artificial Pancreas Devices Systems Sales Growth
4.4 Europe Artificial Pancreas Devices Systems Sales Growth
4.5 Middle East & Africa Artificial Pancreas Devices Systems Sales Growth

5 Americas
5.1 Americas Artificial Pancreas Devices Systems Sales by Country
5.1.1 Americas Artificial Pancreas Devices Systems Sales by Country (2016-2021)
5.1.2 Americas Artificial Pancreas Devices Systems Revenue by Country (2016-2021)
5.2 Americas Artificial Pancreas Devices Systems Sales by Type
5.3 Americas Artificial Pancreas Devices Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Artificial Pancreas Devices Systems Sales by Region
6.1.1 APAC Artificial Pancreas Devices Systems Sales by Region (2016-2021)
6.1.2 APAC Artificial Pancreas Devices Systems Revenue by Region (2016-2021)
6.2 APAC Artificial Pancreas Devices Systems Sales by Type
6.3 APAC Artificial Pancreas Devices Systems Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Artificial Pancreas Devices Systems by Country
7.1.1 Europe Artificial Pancreas Devices Systems Sales by Country (2016-2021)
7.1.2 Europe Artificial Pancreas Devices Systems Revenue by Country (2016-2021)
7.2 Europe Artificial Pancreas Devices Systems Sales by Type
7.3 Europe Artificial Pancreas Devices Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Artificial Pancreas Devices Systems by Country
8.1.1 Middle East & Africa Artificial Pancreas Devices Systems Sales by Country (2016-2021)
8.1.2 Middle East & Africa Artificial Pancreas Devices Systems Revenue by Country (2016-2021)
8.2 Middle East & Africa Artificial Pancreas Devices Systems Sales by Type
8.3 Middle East & Africa Artificial Pancreas Devices Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Artificial Pancreas Devices Systems Distributors
10.3 Artificial Pancreas Devices Systems Customer

11 Global Artificial Pancreas Devices Systems Market Forecast
11.1 Global Artificial Pancreas Devices Systems Forecast by Region
11.1.1 Global Artificial Pancreas Devices Systems Forecast by Regions (2021-2026)
11.2.2 Global Artificial Pancreas Devices Systems Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Artificial Pancreas Devices Systems Forecast by Type
11.7 Global Artificial Pancreas Devices Systems Forecast by Application

12 Key Players Analysis
12.1 Medtronic
12.1.1 Medtronic Company Information
12.1.2 Medtronic Artificial Pancreas Devices Systems Product Offered
12.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Medtronic Main Business Overview
12.1.5 Medtronic Latest Developments
12.2 Bigfoot Biomedical
12.2.1 Bigfoot Biomedical Company Information
12.2.2 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Offered
12.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Bigfoot Biomedical Main Business Overview
12.2.5 Bigfoot Biomedical Latest Developments
12.3 Beta Bionics
12.3.1 Beta Bionics Company Information
12.3.2 Beta Bionics Artificial Pancreas Devices Systems Product Offered
12.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Beta Bionics Main Business Overview
12.3.5 Beta Bionics Latest Developments
12.4 Admetsys
12.4.1 Admetsys Company Information
12.4.2 Admetsys Artificial Pancreas Devices Systems Product Offered
12.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Admetsys Main Business Overview
12.4.5 Admetsys Latest Developments
12.5 Insulet
12.5.1 Insulet Company Information
12.5.2 Insulet Artificial Pancreas Devices Systems Product Offered
12.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Insulet Main Business Overview
12.5.5 Insulet Latest Developments
12.6 Tandem Diabetes Care
12.6.1 Tandem Diabetes Care Company Information
12.6.2 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Offered
12.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Tandem Diabetes Care Main Business Overview
12.6.5 Tandem Diabetes Care Latest Developments
12.7 Defymed
12.7.1 Defymed Company Information
12.7.2 Defymed Artificial Pancreas Devices Systems Product Offered
12.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Defymed Main Business Overview
12.7.5 Defymed Latest Developments

13 Research Findings and Conclusion

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 人工膵臓デバイスシステムの世界市場2021-2026:一時停止しきい値デバイスシステム、ハイブリッド閉ループAPDS、その他システム(Global Artificial Pancreas Devices Systems Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。